Revenue-based financing (RBF) is capital repaid as a fixed percentage of monthly revenue until a total repayment cap is hit.
Revenue-based financing sits between venture debt and equity. You take capital today and repay it as a percentage of monthly revenue — typically 3-10% — until you've repaid a cap of 1.3x-2.0x the original principal. There's no equity dilution, no board seats, no personal guarantees, and no fixed payment schedule that could break you in a slow month. That flexibility comes at a real cost: effective annualized rates land between 15% and 40% depending on how fast you grow. RBF is powerful for the right company at the right moment. It's expensive and constraining for the wrong one.
Take $500K at a 1.5x cap and 6% revenue share. You'll repay $750K total. If revenue is $200K/month, you send $12K/month; the loan retires in ~63 months. If revenue is $500K/month, you send $30K/month and retire it in ~25 months. Faster growth = shorter duration = higher effective IRR to the lender. That's exactly the point: RBF providers are betting on your revenue trajectory, not your terminal value. Model both fast and slow scenarios before signing — the same 1.5x cap can be a 12% APR (slow growth) or a 45% APR (very fast growth).
Companies with (1) predictable recurring revenue — SaaS, subscription commerce, marketplaces with take rate, (2) gross margins above 50% so revenue-share payments don't crush contribution margin, (3) a specific use of funds with clear payback (paid acquisition with proven CAC, inventory for known demand), and (4) either no interest in raising equity now or a deliberate bridge to a stronger equity raise later. RBF is a poor fit for pre-revenue companies, low-margin businesses, or capital used for long-payback R&D.
If you're heading toward hypergrowth and a large equity round in 6-12 months, RBF is expensive dilution-avoidance — a good equity round will make the RBF math look painful in hindsight. If your revenue is lumpy (enterprise contracts booked once a year), the percentage-of-revenue mechanic creates volatile payments that can strain cash. If gross margins are thin, sending 6-10% of revenue off the top can turn a break-even business into a cash-negative one. And if the RBF replaces equity capital that would have funded genuinely uncertain R&D, you're mis-matching capital type to risk profile.
Repayment cap (1.3x-2.0x — anything above 2.0x is expensive), revenue share percentage (lower is better; look for step-downs as revenue grows), definition of 'revenue' (gross vs. net of refunds and chargebacks — gross is worse for you), minimum payment floors (avoid these; they defeat the purpose of RBF), advance-rate on future rounds (some providers want a warrant or MFN — push back), and cure periods for missed reporting. Also read the covenants: RBF providers increasingly require monthly financial reporting, minimum cash balance covenants, and restrictions on additional debt.
Venture debt is cheaper (8-14% APR + warrants) but requires either an existing equity round or a strong balance sheet, comes with fixed monthly payments that can break you in a slow quarter, and usually has covenants. Equity is expensive on the back end (dilution scales with future value) but frees you from any repayment burden and comes with strategic help. RBF is expensive on the front end (15-40% effective cost) but ownership-preserving and cash-flow-flexible. Rule of thumb: use RBF for known-payback growth spend, venture debt for extending runway between equity rounds, and equity for genuinely uncertain long-payback investments.
Investor directory · Fundraising library · Articles A–Z · Company funding database